Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …